Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Invesco Ltd. ( IVZ - Analyst Report ) announced a 0.8% dip in its preliminary month-end assets under management (AUM) for the month of October 2012. The AUM for the month came in at $677.4 billion compared with $683.0 billion at the end of September.
Unfavorable market returns, negative foreign exchange and total net outflows, driven by $2.2 billion of outflow in the Invesco PowerShares QQQ, were the primary reasons for the decline in AUM. Moreover, foreign exchange led to a $1.1 billion drop in AUM. During the period, the company’s active AUM witnessed positive long-term net inflows.
In the month under review, Invesco’s preliminary active AUM was recorded at $563.4 billion, reflecting a 0.3% fall from $565.1 billion in the prior month. Likewise, preliminary passive AUM was $114.0 billion, down 3.3% from $117.9 billion in the last month.
As of October 31, 2012, Invesco’s average assets stood at $679.2 billion, while the total value of average active assets was $564.6 billion.
At the end of October, Invesco’s total equity assets slipped 2.8% to $292.3 billion from $300.6 billion recorded at the end of September. However, the company’s fixed income assets inched up 1.0% to $168.7 billion from $167.0 billion in the preceding month.
Invesco’s balanced assets summed up to $58.9 billion, rising 1.7% from the previous month. However, alternative AUM remained almost flat compared with the prior month at $84.2 billion.
Moreover, Invesco’s money market AUM came in at $73.3 billion in the reported month, almost at par with the prior month’s level of $73.2 billion.
Last week, Franklin Resources Inc. ( BEN - Analyst Report ) declared preliminary assets under management (AUM) of $753.9 billion by its subsidiaries for October 2012. The company’s results rose 0.5% from $749.9 billion as of September 30, 2012. Moreover, it increased 8.6% from $694.1 billion as of October 31, 2011.
Invesco’s broad diversification strategy positions it comfortably to benefit from enhanced global investment flows. However, the unstable U.S. dollar, volatile equity markets and a sluggish economic recovery, along with mounting competition, make us apprehensive.
Invesco currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. Considering the fundamentals, we also maintain a long-term ‘Neutral’ recommendation on the stock.
Read the full reports :
Analyst Report on IVZ
Analyst Report on BEN